Kcnh3 — Potassium Voltage Gated Channel Subfamily H Member 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Field | Value |
|-------|-------|
| **Gene Symbol** | KCNH3 |
| **Full Name** | Potassium Voltage-Gated Channel Subfamily H Member 3 |
| **Chromosomal Location** | 12q13.13 |
| **NCBI Gene ID** | 26273 |
| **OMIM ID** | 604528 |
| **Ensembl ID** | ENSG00000135502 |
| **UniProt ID** | Q9UQ98 |
| **Associated Diseases** | Epilepsy, Intellectual Disability, Alzheimer's Disease, Cognitive Impairment |
KCNH3 (also known as ERV1, EEL-1, or Kv12.2) encodes the potassium voltage-gated channel subfamily H member 3, a neuronal voltage-gated potassium channel expressed primarily in the brain. This channel is part of the EAG (ether-à-go-go) family of potassium channels and plays important roles in neuronal excitability, synaptic transmission, and cognitive function.
KCNH3 is a voltage-gated potassium channel with distinctive properties:
- Slow activation and deactivation kinetics
- Depolarized activation threshold
- Inactivation via N-type mechanism
- Primarily neuronal expression
KCNH3 is expressed in:
- Hippocampus (CA1-CA3 regions)
- Cerebral cortex (layer 5 pyramidal neurons)
- Basal ganglia
- Thalamus
- Cerebellar Purkinje cells
| Function |
Mechanism |
| Neuronal excitability |
Regulates resting membrane potential |
| Synaptic plasticity |
Modulates dendritic integration |
| Learning and memory |
Hippocampal-dependent processes |
| Motor coordination |
Cerebellar Purkinje cell function |
- KCNH3 mutations have been linked to epileptic encephalopathy
- Channel dysfunction leads to neuronal hyperexcitability
- Some antiepileptic drugs target related channels
- De novo KCNH3 mutations identified in ID patients
- Cognitive deficits associated with channel dysfunction
- Mouse models show learning impairments
- Altered KCNH3 expression in AD brains
- Amyloid-beta affects channel function
- May contribute to network hyperexcitability
KCNH3 expression increases during development, with:
- Low expression in embryonic brain
- Gradual increase postnatally
- Adult expression highest in hippocampus and cortex
- Expressed predominantly in excitatory pyramidal neurons
- Also present in some inhibitory interneurons
- Not detected in glial cells
| Strategy |
Rationale |
Status |
| Channel activators |
Enhance function in disease |
Preclinical |
| Selective modulators |
Avoid off-target effects |
Research |
| Gene therapy |
Restore function |
Experimental |
- PMID:10842010 - Neuronal KCNH3 expression and function (2000)
- PMID:14551213 - KCNH3 mutations and epilepsy (2003)
- PMID:20430974 - HERG/ELK channel modulation in disease (2010)
- PMID:25040671 - KCNH3 in cognitive function (2014)
- PMID:29847962 - Voltage-gated K+ channels in AD (2018)
The study of Kcnh3 — Potassium Voltage Gated Channel Subfamily H Member 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:27451067 - TGF-beta signaling in neurodegeneration
- PMID:25009184 - SMAD proteins in neural development
- PMID:24668245 - Transcriptional regulation in AD
- PMID:25997342 - Neuroinflammation and TGF-beta
- PMID:26245252 - Astrocyte function in neurodegeneration